We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

287 hedge funds and large institutions have $5.38B invested in United Therapeutics in 2013 Q2 according to their latest regulatory filings, with 287 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $13.1M

Holders
287
Holders Change
+287
Holders Change %
–
% of All Funds
9.37%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
287
Increased
–
Reduced
–
Closed
–
Calls
$13.5M
Puts
$13.1M
Net Calls
+$400K
Net Calls Change
+$400K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WCM
76
Waterstone Capital Management
Minnesota
$8.62M +$8.43M +130,913 New
CEP
77
Chicago Equity Partners
Illinois
$8.14M +$7.97M +123,750 New
Principal Financial Group
78
Principal Financial Group
Iowa
$7.93M +$7.76M +120,498 New
CS
79
Credit Suisse
Switzerland
$7.88M +$7.71M +119,636 New
BIM
80
Bogle Investment Management
Massachusetts
$7.83M +$7.66M +118,943 New
PPA
81
Parametric Portfolio Associates
Washington
$7.74M +$7.58M +117,595 New
AIG
82
American International Group
New York
$7.53M +$7.37M +114,358 New
MCM
83
Maryland Capital Management
Maryland
$7.37M +$7.21M +111,980 New
State Board of Administration of Florida Retirement System
84
State Board of Administration of Florida Retirement System
Florida
$7.27M +$7.12M +110,481 New
New York State Teachers Retirement System (NYSTRS)
85
New York State Teachers Retirement System (NYSTRS)
New York
$7.06M +$6.91M +107,279 New
Asset Management One
86
Asset Management One
Japan
$6.91M +$6.76M +104,958 New
VanEck Associates
87
VanEck Associates
New York
$6.83M +$6.69M +103,819 New
Two Sigma Investments
88
Two Sigma Investments
New York
$6.8M +$6.66M +103,354 New
Ameriprise
89
Ameriprise
Minnesota
$6.54M +$6.4M +99,387 New
Canada Life
90
Canada Life
Manitoba, Canada
$6.5M +$6.36M +98,703 New
Los Angeles Capital Management
91
Los Angeles Capital Management
California
$6.44M +$6.3M +97,873 New
State of Wisconsin Investment Board
92
State of Wisconsin Investment Board
Wisconsin
$6.39M +$6.26M +97,161 New
Federated Hermes
93
Federated Hermes
Pennsylvania
$6.22M +$6.09M +94,530 New
Jacobs Levy Equity Management
94
Jacobs Levy Equity Management
New Jersey
$6.22M +$6.08M +94,434 New
PI
95
Putnam Investments
Massachusetts
$6.2M +$6.06M +94,134 New
QCMC
96
Quantum Capital Management (California)
California
$6.13M +$6M +93,091 New
Bank of America
97
Bank of America
North Carolina
$5.98M +$5.85M +90,802 New
JIM
98
Jupiter Investment Management
United Kingdom
$5.85M +$5.72M +88,850 New
ARTA
99
A.R.T. Advisors
New York
$5.66M +$5.54M +85,979 New
RhumbLine Advisers
100
RhumbLine Advisers
Massachusetts
$5.57M +$5.45M +84,585 New
2 3
4
5 6

UTHR Hedge Fund Activity: Q2 2013 in Review

287 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2013, worth a combined $5.38B.

Buyers outnumbered sellers: 287 funds opened new UTHR positions and 0 closed out — a net gain of 287 holders — while 0 added to existing stakes and 0 trimmed.

  • 287 institutional investors held United Therapeutics (UTHR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.38B of United Therapeutics stock for Q2 2013.
  • 287 funds opened new United Therapeutics positions in Q2 2013 and 0 closed out, a net change of +287 holders.

Based on aggregated 13F filings for Q2 2013.